Hussam Abuissa, MD
Clinical Cardiac Electrophysiology · Omaha, NENPI 1679500862
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $101,125 of the $161,862 with a category attached, or 62.5%. Abbott accounts for 85.2% of it on its own, with 25 other manufacturers making up the rest. Among clinical cardiac electrophysiology clinicians in NE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 381 payments — averaging $424.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$138K
- Medtronic$14K
- Boston Scientific$7K
- Biosense Webster, Inc.$562
- Atricure, Inc.$317
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$203
- plus $1K from 20 others
Across 23 payments — averaging $1278.51 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$18K
- Abbott$11K
What the payments were for
- Consulting fees$101,12562%
- Speaking & faculty fees$9,8856%
- Travel & lodging$37,61323%
- Food & beverage$13,2408%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 175 | $137,874 |
| Medtronic(2 entities) | 80 | $14,392 |
| Boston Scientific | 60 | $7,464 |
| Biosense Webster, Inc. | 13 | $562 |
| Atricure, Inc. | 3 | $317 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 13 | $203 |
| Edwards Lifesciences | 3 | $203 |
| Pfizer | 5 | $136 |
| ZOLL Respicardia, Inc. | 1 | $130 |
| Philips North America LLC | 4 | $81 |
| Impulse Dynamics (USA) Inc. | 3 | $80 |
| Cardiva Medical, Inc. | 2 | $76 |
| Sanofi-aventis U.S. LLC | 3 | $51 |
| Johnson & Johnson | 1 | $35 |
| Scpharmaceuticals Inc. | 2 | $34 |
| Boehringer Ingelheim | 2 | $31 |
| Chiesi USA, Inc. | 2 | $31 |
| Baylis Medical Company Inc | 1 | $29 |
| Cardiovascular Systems Inc. | 1 | $25 |
| E.r. Squibb & Sons, L.L.C. | 1 | $20 |
| Irhythm Technologies, Inc. | 1 | $20 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $17 |
| Preventice Services, LLC | 1 | $15 |
| Amgen | 1 | $15 |
| Davol Inc. | 1 | $11 |
| Altathera Pharmaceuticals LLC | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMPLATZER AMULET$128,856
- Arctic Front$4,130
- GENERAL - THERAPIES$3,631
- JETi All In One Non-Sterile Kit$2,750
- AVEIR$2,229
- Watchman$1,210
- Rhythmia Mapping System$983
- EVERA MRI XT DR SURESCAN$768
- ARCTIC FRONT ADVANCE$581
- CARDIOBLATE CRYOFLEX$443
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$297
- Carto 3$265
- AMPLATZER Occluders$184
- Merlin Connectivity and Remote$175
- AMPLATZER TALISMAN$172
- AURORA EV-ICD MRI SURESCAN$171
- ABSOLUTE PRO$161
- TRICLIP$160
- EVOQUE$151
- XIENCE SIERRA$146
How this compares
$161,862 in reported general payments places this provider in the 95th percentile of 21 clinical cardiac electrophysiology providers in Nebraska.
See all clinical cardiac electrophysiology providers in Nebraska →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 231 | $226,741 |
| XareltoRivaroxaban | 50 | $51,263 |
| MultaqDronedarone Hcl | 13 | $23,221 |
| Flecainide Acetate | 100 | $3,130 |
| Amiodarone Hcl | 154 | $1,980 |
| Metoprolol Succinate | 150 | $1,646 |
| ClopidogrelClopidogrel Bisulfate | 91 | $642 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 26 | $596 |
| SotalolSotalol Hcl | 28 | $424 |
| Warfarin Sodium | 54 | $423 |
| Mupirocin | 40 | $319 |
| Pantoprazole Sodium | 22 | $258 |
| Doxycycline Hyclate | 22 | $205 |
| Metoprolol Tartrate | 20 | $121 |
| Tiadylt ErDiltiazem Hcl | 11 | $113 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $136 | $226,741231 claims |
| Johnson & JohnsonXarelto | $35 | $51,26350 claims |
| Sanofi-aventis U.S. LLCMultaq | $51 | $23,22113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 21 clinical cardiac electrophysiology providers in Nebraska.
Other clinical cardiac electrophysiology in Omaha
- Jeffrey MahoneyOmaha$118K
- Shane TsaiOmaha$68K
- Jason PayneOmaha$59K
- Matthew SorensenOmaha$30K
- David SternsOmaha$28K
- Matthew KapalisOmaha$24K
- Christopher EricksonOmaha$18K
- Matthew LatachaOmaha$14K
- Daniel VariOmaha$9K
- John SchleiferOmaha$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.